AsPEN Office
School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences,
National Cheng Kung University, Taiwan
Contact
Secretary : Hong-Chia (Hong+)
Email : yumemi@hourcenter.org.tw
National Groups and Contact Persons
Australia
Members:
Frank May, Drug and Therapeutics Information Service
Libby Roughead, University of South Australia
Nicole Pratt, University of South Australia
Contact:
Dr. Libby Roughead
Division of Health Sciences, School of Pharmacy and Medical Sciences, University of South Australia
Email:Libby.Roughead@unisa.edu.au
Canada
Members:
Hongbo Yuan, Canadian Agency for Drugs and Technologies in Health
Contact:
Hongbo Yuan, MD, MSc, PhD
Canadian Agency for Drugs and Technologies in Health
Email:HongboY@cadth.ca
China
Members:
Du Wenmin, Shanghai Drug Monitoring and Evaluative System, SDMES
Jasmanda Wu, Sanofi, China
Siyan Zhan, Peking University Health Science Center
Tengfei Man, Merck Research Laboratories
Wei Zhou, Merck Research Laboratories
Yan Miao, Merck Research Laboratories, China
Contact:
Siyan Zhan, MD, PhD
Department of Epidemiology and Bio-statistics, Peking University Health Science Center
Email: siyan-zhan@bjmu.edu.cn
Wei Zhou, MD, PhD
Regional Director and Head, Epidemiology Asia Pacific Unit, Merck Research Laboratories
Email:wei.zhou2@merck.com
Hong Kong
Member:
Ian Chi Kei Wong, University of Hong Kong
Kenneth Man, University of Hong Kong
Contact:
Prof. Ian Chi Kei Wong
Department of Pharmacology and Pharmacy, University of Hong Kong
Email:wongick@hku.hk
Japan
Members:
Hiraku Kumamaru, University of Tokyo
John Cai, MSD K.K.
Kiyoshi Kubota, NPO DSRU Japan
Nobuhiro Ooba, School of Pharmacy, Nihon University, DSRU Japan
Tomomi Kimura, Janssen Pharmaceutical K.K.
Tsugumichi Sato, Tokyo University of Science, DSRU Japan
Yukari Kamijima, DSRU Japan
Contact:
Kiyoshi Kubota, MD, PhD, FISPE
Drug Safty Research Unit Japan (DSRU Japan)
Email: kubotape-tky@umin.net
Korea
Members:
Byung Joo Park, Seoul National University College of Medicine
Joongyub Lee, Medical Research Collaborating Center, Seoul National University Hospital / Seoul National University College of Medicine
Ju-Young Shin, School of Pharmacy, SungKyungKwan University (SKKU)
Nam-Kyong Choi, Department of Health Convergence, Ewha Womans University
Contacts:
Byung Joo Park, Professor, FISPE
Department of Preventive Medicine, Seoul National University College of Medicine
Email: bjpark@snu.ac.kr
Ju-Young Shin
School of Pharmacy, SungKyungKwan University (SKKU)
Email: shin.jy@skku.edu
Singapore
Member:
Wai Ping Yau, National University of Singapore
Wee Hwee Lin, National University of Singapore
Yan-Fang Liu, Janssen, Singapore
Contact:
Wai Ping Yau, PhD
Department of Pharmacy, National University of Singapore
E-mail: phaywp@nus.edu.sg
Sweden
Members:
Morten Andersen, Karolinska Institute
Ulf Bergman, Karolinska Institute
Contacts:
Prof. Morten Andersen
Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital
Email: Morten.Andersen@ki.se
Ulf Bergman, MD, PhD, FISPE, FRCP
Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital
Email: Ulf.Bergman@ki.se
Taiwan
Members:
Ching-Lan Chang, National Cheng Kung University
Edward Chia-Cheng Lai, National Cheng Kung University
Hsu-Chih Chien, National Cheng Kung University
Tz-Chieh Lin, National Cheng Kung University
Ya-Chuan Chang, National Cheng Kung University
Yea-Huei Kao Yang, National Cheng Kung University
Contact:
Yea-Huei Kao Yang, Professor, FISPE
Institute of Clinical Pharmacy and Pharmaceutical Sciences, and Health Outcome Research Center, National Cheng Kung University
E-mail:yhkao@mail.ncku.edu.tw
Thailand
Members:
Sawaeng Watcharathanakij, Ubon Ratchathani University
Contact:
Sawaeng Watcharathanakij, RPh, PhD.
Faculty of Pharmaceutical Sciences, Ubon Ratchathani University
Email: phsawaeng@mail2.ubu.ac.th
United States
Members:
Cecilia Huang, Rutgers University
Chih-Ying Chen, Brigham and Women’s Hospital
Cynthia de Luise, Pfizer Inc., USA
James Stark, Pfizer Inc., USA
Jassica Jalbert, LA-SER Analytica
Kui Huang, Pfizer Inc., China
Lin Li, Boston University
Qian Li, Harvard School of Public Health
Soko Setoguchi, Duke Clinical Research Institute
Tobias Gerhard, Rutgers University
Wei Liu, University of Florida
Xiaojuan Li, University of North Carolina at Chapel Hill
Contact:
Soko Setoguchi, MD, DrPH, FISPE
Duke Clinical Research Institute and University of Tokyo
Email: soko.setoguchi@duke.edu
